Esther Rajavelu, CEO, CFO and Chief Business Officer at Spero Therapeutics, holds 1.01M shares in Spero Therapeutics (Ticker: SPRO), holds ― shares in Fulcrum Therapeutics (Ticker: FULC). Most recently, Esther Rajavelu Sold ― shares of Spero Therapeutics on May 06, 2026 for an estimated value of $63.35K.
What is the percentage of profitable transactions made by Esther Rajavelu?
The percentage of profitable transactions made by Esther Rajavelu is 67%.
What is the average return per transaction made by Esther Rajavelu?
The average return per transaction made by Esther Rajavelu is -10.70%.
What stocks does Esther Rajavelu hold?
Esther Rajavelu holds: SPRO, FULC stocks.
What was Esther Rajavelu’s latest transaction?
Esther Rajavelu latest transaction was an Informative Sell of $63.35K.
What was Esther Rajavelu's most profitable transaction?
Esther Rajavelu’s most profitable transaction was an Informative Sell of SPRO stock on November 12, 2025. The return on the trade was 53.70%.
What is Esther Rajavelu's role in Spero Therapeutics?
Esther Rajavelu's role in Spero Therapeutics is CEO, CFO and Chief Business Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.